Annals of Neurology,
Journal Year:
2017,
Volume and Issue:
81(3), P. 369 - 382
Published: Feb. 21, 2017
Almost
half
the
cells
and
1%
of
unique
genes
found
in
our
bodies
are
human,
rest
from
microbes,
predominantly
bacteria,
archaea,
fungi,
viruses.
These
microorganisms
collectively
form
human
microbiota,
with
most
colonizing
gut.
Recent
technological
advances,
open
access
data
libraries,
application
high‐throughput
sequencing
have
allowed
these
microbes
to
be
identified
their
contribution
neurological
health
examined.
Emerging
evidence
links
perturbations
gut
microbiota
disease,
including
disease
risk,
activity,
progression.
This
review
provides
an
overview
recent
advances
microbiome
research
relation
neuro(auto)immune
neurodegenerative
conditions
affecting
humans,
such
as
multiple
sclerosis,
neuromyelitis
optica
spectrum
disorders,
Parkinson
Alzheimer
Huntington
amyotrophic
lateral
sclerosis.
Study
design
terminology
used
this
rapidly
evolving,
highly
multidisciplinary
field
summarized
empower
engage
neurology
community
“newly
discovered
organ.”
Ann
Neurol
2017;81:369–382
Future Microbiology,
Journal Year:
2017,
Volume and Issue:
12(2), P. 157 - 170
Published: Jan. 31, 2017
The
genus
Roseburia
consists
of
obligate
Gram-positive
anaerobic
bacteria
that
are
slightly
curved,
rod-shaped
and
motile
by
means
multiple
subterminal
flagella.
It
includes
five
species:
intestinalis,
R.
hominis,
inulinivorans,
faecis
cecicola.
Gut
spp.
metabolize
dietary
components
stimulate
their
proliferation
metabolic
activities.
They
part
commensal
producing
short-chain
fatty
acids,
especially
butyrate,
affecting
colonic
motility,
immunity
maintenance
anti-inflammatory
properties.
Modification
in
representation
may
affect
various
pathways
is
associated
with
several
diseases
(including
irritable
bowel
syndrome,
obesity,
Type
2
diabetes,
nervous
system
conditions
allergies).
could
also
serve
as
biomarkers
for
symptomatic
pathologies
(e.g.,
gallstone
formation)
or
probiotics
restoration
beneficial
flora.
Genome Medicine,
Journal Year:
2017,
Volume and Issue:
9(1)
Published: April 26, 2017
Parkinson's
disease
(PD)
presently
is
conceptualized
as
a
protein
aggregation
in
which
pathology
involves
both
the
enteric
and
central
nervous
system,
possibly
spreading
from
one
to
another
via
vagus
nerves.
As
gastrointestinal
dysfunction
often
precedes
or
parallels
motor
symptoms,
system
with
its
vast
diversity
of
microorganisms
may
be
involved
PD
pathogenesis.
Alterations
microbial
taxonomic
level
L-DOPA-naïve
patients
might
also
serve
biomarker.
We
performed
metagenomic
shotgun
analyses
compared
fecal
microbiomes
31
early
stage,
28
age-matched
controls.
found
increased
Verrucomicrobiaceae
(Akkermansia
muciniphila)
unclassified
Firmicutes,
whereas
Prevotellaceae
(Prevotella
copri)
Erysipelotrichaceae
(Eubacterium
biforme)
were
markedly
lowered
samples.
The
observed
differences
could
reliably
separate
control
ROC-AUC
0.84.
Functional
metagenomes
revealed
microbiota
metabolism
involving
ẞ-glucuronate
tryptophan
metabolism.
While
abundances
prophages
plasmids
did
not
differ
between
controls,
total
virus
abundance
was
decreased
participants.
Based
on
our
analyses,
intake
either
MAO
inhibitor,
amantadine,
dopamine
agonist
(which
summary
relates
90%
patients)
had
no
overall
influence
taxa
functions.
Our
data
colonic
controls
at
an
unprecedented
detail
achievable
through
16S
sequencing.
findings
point
yet
unappreciated
aspect
PD,
intestinal
barrier
function
immune
patients.
parkinsonian
medication
should
further
investigated
future
larger
cohorts.
npj Parkinson s Disease,
Journal Year:
2021,
Volume and Issue:
7(1)
Published: March 10, 2021
The
gut
microbiota
is
emerging
as
an
important
modulator
of
neurodegenerative
diseases,
and
accumulating
evidence
has
linked
microbes
to
Parkinson's
disease
(PD)
symptomatology
pathophysiology.
PD
often
preceded
by
gastrointestinal
symptoms
alterations
the
enteric
nervous
system
accompany
disease.
Several
studies
have
analyzed
microbiome
in
PD,
but
a
consensus
on
features
PD-specific
missing.
Here,
we
conduct
meta-analysis
re-analyzing
ten
currently
available
16S
datasets
investigate
whether
common
patients
exist
across
cohorts.
We
found
significant
PD-associated
microbiome,
which
are
robust
study-specific
technical
heterogeneities,
although
differences
structure
between
controls
small.
Enrichment
genera
Lactobacillus,
Akkermansia,
Bifidobacterium
depletion
bacteria
belonging
Lachnospiraceae
family
Faecalibacterium
genus,
both
short-chain
fatty
acids
producers,
emerged
most
consistent
alterations.
This
dysbiosis
might
result
pro-inflammatory
status
could
be
recurrent
affecting
patients.
Annals of Neurology,
Journal Year:
2017,
Volume and Issue:
81(3), P. 369 - 382
Published: Feb. 21, 2017
Almost
half
the
cells
and
1%
of
unique
genes
found
in
our
bodies
are
human,
rest
from
microbes,
predominantly
bacteria,
archaea,
fungi,
viruses.
These
microorganisms
collectively
form
human
microbiota,
with
most
colonizing
gut.
Recent
technological
advances,
open
access
data
libraries,
application
high‐throughput
sequencing
have
allowed
these
microbes
to
be
identified
their
contribution
neurological
health
examined.
Emerging
evidence
links
perturbations
gut
microbiota
disease,
including
disease
risk,
activity,
progression.
This
review
provides
an
overview
recent
advances
microbiome
research
relation
neuro(auto)immune
neurodegenerative
conditions
affecting
humans,
such
as
multiple
sclerosis,
neuromyelitis
optica
spectrum
disorders,
Parkinson
Alzheimer
Huntington
amyotrophic
lateral
sclerosis.
Study
design
terminology
used
this
rapidly
evolving,
highly
multidisciplinary
field
summarized
empower
engage
neurology
community
“newly
discovered
organ.”
Ann
Neurol
2017;81:369–382